Navigation Links
JACO WS-14 Wall Mounted Tablet Security System Announcement
Date:11/4/2013

FRANKLIN, Mass., Nov. 4, 2013 /PRNewswire/ -- JACO, Inc., an industry leader in the design and fabrication of point-of-care mobile computer carts and wall mounted computer technology, is proud to announce the release of its new WS-14 Tablet Wall Mount Series. With a complete line of products known for durable metal construction, antimicrobial infection control, and safe and easy access, JACO's new WS-14 paves the way for the emerging tablet computer access electronic health records market.  Designed to accommodate virtually every model tablet computer, and customizable to meet the needs of each unique customer's requirements, safe and reliable wall mounted tablet access is now at your finger tips.

(Logo: http://photos.prnewswire.com/prnh/20130214/NE60037LOGO-a)

Tom Bagley, VP of Engineering, shares, "We have experienced increased demand for new tablet computer mounting solutions in the healthcare marketplace.  Complementing our UltraLite 100 Tablet Series Mobile Computer Carts perfectly, The WS-14 provides caregivers with a simple solution for storing tablets that are best suited in their workflow for wall mounted, secure locking access.  There is no question that tablet computer access is here to stay, and here at JACO, we are looking to provide the industry with completely customizable solutions designed to every customer's specific requests. By designing and manufacturing our products out of metal, we are able to provide the customization IT professionals and clinical staffs need without incurring expensive tooling costs that plastic based manufacturers are constrained by. Customization is just one of our many unique advantages here at JACO."

JACO Wall Stations aim to provide nurse and physicians with a secure and effective way to access vital patient information anywhere.  Utilizing American-Made aluminum and steel based construction, JACO products are sealed with a non-porous, smooth antimicrobial powder-coat finish for optimal infection control. Products will not scratch, crack, or fade over time, and will providing the long-term durability and a healthy return-on-investment that healthcare IT decision makers have been looking for. The WS-14 Series is designed to work with top industry tablets including the following series: Apple iPads, Lenovo ThinkPads, HP EliteBooks and many more.  Products are available for trial evaluation and immediate sale.

About JACO

JACO, Inc., located in Franklin, Massachusetts, is a leading manufacturer and integrator of point-of-care Electronic Medical Records (EMR) mobile computer carts, wall stations and wall arm technology.  Proudly manufacturing products in the United States of America for over 40 years, JACO has set the healthcare industry standard for overall product performance, sustainable quality, ergonomic design and safety, and exceptional customer service. JACO is a nationally certified Woman Owned Small Business and Woman's Business Enterprise by the Women's Business Enterprise National Council (WBENC) and is an ISO 9001-2008 Registered Company.

More information is available at www.jacoinc.com or 800-649-2278.


'/>"/>
SOURCE JACO, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AVT Unveils New Wall Mounted Automated Medicine Information and Dispensing System
2. ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV
3. Par Pharmaceutical Begins Shipment of KHEDEZLA (desvenlafaxine) Extended-release Tablets, 50 mg and 100 mg
4. Sanofi US and POZEN Sign Exclusive License Agreement for the Commercialization of PA8140/PA32540 Tablets in the U.S.
5. Mylan Confirms Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg
6. Par Pharmaceutical Receives Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg
7. Physicians Expect More Out of Tablet-Toting Pharmaceutical Sales Reps, Study Finds
8. Insight Pharmaceuticals Considers Bananacin -- Banana-Flavored Anacin Tablets -- After Worlds Oldest Man Credits Combo As Secret To Long Life
9. Third Circuit Rules in Mylans Favor Regarding Paroxetine Hydrochloride Extended-Release Tablets, Sending Mylans Breach of Contract Claim Against GSK to Trial
10. Zydus Pharmaceuticals USA Inc. Issues Voluntary Nationwide Recall of Warfarin 2 mg Tablets, Lot MM5767, Expiration Date June 2014, Due to Oversized Tablets
11. TWi Pharmaceuticals Announces Tentative ANDA Approval for Guanfacine Hydrochloride Extended-Release Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... EAST HANOVER, N.J. , April 19, 2017 ... study conducted by the National Heart, Lung, and ... Health (NIH) demonstrating that 58% of patients with ... at six months when treated with eltrombopag at ... treatment 1 . The study evaluated three sequential ...
(Date:4/18/2017)... April 18, 2017 Cogentix Medical, Inc. (NASDAQ: ... the Urology, Uro/Gyn and Gynecology markets with innovative and ... quarter ended March 31, 2017 after the market close ... Company will host a conference call and webcast to ... May 2, 2017 at 4:30 p.m. Eastern Time (3:30 ...
(Date:4/18/2017)... 2017  Astute Medical, Inc., developer of biomarkers for ... presented at the 2017 National Kidney Foundation (NKF) ... through April 22. Physicians will present data on two ... risk for acute kidney injury (AKI) during the management ... Elevated levels of TIMP-2 and IGFBP-7 have ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... The John P. McGovern Museum of Health ... anywhere to track their cognitive health, and share results with their physicians. Members and ... on the museum's website. , BrainCheck founder, Dr. David Eagleman, formerly at Baylor College ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... and credentialing solutions, today announced that Kyle Allain has joined the company as ... Management sales and operations, including provider, payor and managed care solutions. , ...
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, a relatively new ... is not known to have significant interactions with antiretroviral therapy (ART). Among ... levels and dampen inflammation in the bloodstream. , While lowering cholesterol and dampening ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... that over the last decade, student well-being has seriously declined. "When disenfranchised youth ... formal education, join the Islamic State to turn the historic multi-ethnic and multi-religious ...
(Date:4/24/2017)... ... April 24, 2017 , ... Life of Purpose Treatment is proud to present ... be held at 7:30 pm on May 10th at the University Auditorium. , This ... Hazel, will support the UF Collegiate Recovery Community (UFCRC). The concert will kick off ...
Breaking Medicine News(10 mins):